JP2013511530A - ライム病抗体の検出のためのペプチドおよび方法 - Google Patents

ライム病抗体の検出のためのペプチドおよび方法 Download PDF

Info

Publication number
JP2013511530A
JP2013511530A JP2012540005A JP2012540005A JP2013511530A JP 2013511530 A JP2013511530 A JP 2013511530A JP 2012540005 A JP2012540005 A JP 2012540005A JP 2012540005 A JP2012540005 A JP 2012540005A JP 2013511530 A JP2013511530 A JP 2013511530A
Authority
JP
Japan
Prior art keywords
group
amino acid
acid selected
peptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012540005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511530A5 (enExample
Inventor
ラジェシュ ケイ． メーラ
ケネス ピー． アロン
デニス エム． ブレイル
Original Assignee
アバクシス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アバクシス， インコーポレイテッド filed Critical アバクシス， インコーポレイテッド
Publication of JP2013511530A publication Critical patent/JP2013511530A/ja
Publication of JP2013511530A5 publication Critical patent/JP2013511530A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
JP2012540005A 2009-11-17 2010-11-17 ライム病抗体の検出のためのペプチドおよび方法 Pending JP2013511530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26209909P 2009-11-17 2009-11-17
US61/262,099 2009-11-17
PCT/US2010/057053 WO2011063003A2 (en) 2009-11-17 2010-11-17 Peptides and methods for the detection of lyme disease antibodies

Publications (2)

Publication Number Publication Date
JP2013511530A true JP2013511530A (ja) 2013-04-04
JP2013511530A5 JP2013511530A5 (enExample) 2013-12-26

Family

ID=44060312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540005A Pending JP2013511530A (ja) 2009-11-17 2010-11-17 ライム病抗体の検出のためのペプチドおよび方法

Country Status (8)

Country Link
US (1) US8568989B2 (enExample)
EP (1) EP2501719B1 (enExample)
JP (1) JP2013511530A (enExample)
KR (1) KR20120096932A (enExample)
CN (1) CN102791727A (enExample)
AU (1) AU2010322085B2 (enExample)
CA (1) CA2781110C (enExample)
WO (1) WO2011063003A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758772B2 (en) * 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
DK3489685T3 (da) * 2011-11-21 2023-12-04 Zoetis Services Llc Signalforstærkning i sidestrømning og tilsvarende immunoassays
JP2013164414A (ja) * 2012-01-13 2013-08-22 Nippon Meat Packers Inc 抗菌ペプチドを用いた微生物の検出方法及び検出用キット
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
WO2015160834A1 (en) * 2014-04-14 2015-10-22 Abreos Biosciences, Inc. Lateral flow immunoassay
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
WO2016049148A1 (en) * 2014-09-24 2016-03-31 Wellstat Diagnostics, Llc Compositions and methods for te diagnosis of lyme disease
CN104330555B (zh) * 2014-10-22 2016-05-11 中国检验检疫科学研究院 检测伯氏疏螺旋体抗体的试纸、试纸制备方法及试剂盒
JP6944438B2 (ja) 2015-08-04 2021-10-06 ゾエティス サービシズ リミテッド ライアビリティ カンパニー 溶液ベースのプラズモン特異的結合パートナーアッセイにおけるシグナル増幅
EP4538705A3 (en) 2015-08-27 2025-07-02 Ortho-Clinical Diagnostics, Inc. Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes
CN105548577B (zh) * 2016-02-04 2017-09-19 安徽医科大学 一种琥珀酰‑β‑环糊精修饰的莱姆病检测用蛋白质芯片及其制备与应用
EP3252470B1 (en) 2016-06-03 2020-07-29 Te?ted Oy A method and a solid support for detecting tick-borne microbes in a biological sample
USD800912S1 (en) 2016-06-17 2017-10-24 Abreos Biosciences, Inc. Point-of-care diagnostic device
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
KR102654470B1 (ko) 2017-01-30 2024-04-05 조에티스 서비시즈 엘엘씨 용액-기반 플라스몬 특이적-결합 파트너 검정 및 금속성 나노구조체
JP7062803B1 (ja) * 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
EP4220166A1 (en) 2022-02-01 2023-08-02 Universitat Rovira I Virgili (URV) In vitro method for detecting antibodies in a sample
WO2023196781A1 (en) * 2022-04-04 2023-10-12 Antigen Discovery Inc. Antigens for detection of early lyme disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000065064A1 (en) * 1999-04-28 2000-11-02 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
WO2002090961A2 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US20060194267A1 (en) * 2005-02-25 2006-08-31 Aristo Vojdani Methods and kit for diagnosing tick borne illnesses
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4888276A (en) 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5385826A (en) 1989-04-21 1995-01-31 Gundersen Medical Foundation, Ltd. Diagnostic assay for lyme disease
DE4015911A1 (de) 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5187065A (en) 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
WO1992000055A1 (en) 1990-06-15 1992-01-09 Yale University Compositions and methods for the prevention and diagnosis of lyme disease
US5155022A (en) 1991-02-08 1992-10-13 Becton, Dickinson And Company Assay for lyme disease
US5324630A (en) 1991-06-28 1994-06-28 The Regents Of The University Of California Methods and compositions for diagnosing lyme disease
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
WO1993003184A1 (en) 1991-08-09 1993-02-18 Mccann Associates, Inc. Method for detecting lyme disease and composition
US5965702A (en) 1991-10-21 1999-10-12 Abbott Laboratories Borrelia burgdorferi antigens and uses thereof
US5618533A (en) 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5308753A (en) 1992-02-20 1994-05-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for purifying and detecting IGM antibodies
US5620862A (en) 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
US5932220A (en) 1995-05-08 1999-08-03 Board Of Regents University Of Texas System Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
WO1997031123A1 (en) 1996-02-21 1997-08-28 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6902893B1 (en) 1997-06-20 2005-06-07 Gil H. Choi Lyme disease vaccines
CA2294701C (en) 1997-06-30 2009-09-08 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6667038B1 (en) 1999-04-21 2003-12-23 Boston Medical Center Corp. Prevention, diagnosis and treatment of lyme disease
US6665652B1 (en) 1999-07-28 2003-12-16 Richard B. Porwancher Method of diagnosis of lyme disease
US6838247B2 (en) 2002-06-19 2005-01-04 Bowen Research And Training Test for lyme disease
WO2004058181A2 (en) 2002-12-20 2004-07-15 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia species and strains
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
ATE467128T1 (de) 2005-03-29 2010-05-15 Inverness Medical Switzerland Kolloidale metallkonjugate
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
CA2690904C (en) 2007-06-27 2015-11-03 Inbios International, Inc. Lateral flow assay system and methods for its use
EP2058663A1 (en) 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Method for the immobilization of an analyte on a solid support
JP2009236685A (ja) 2008-03-27 2009-10-15 Sysmex Corp クロマトグラフィー用試験具

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000065064A1 (en) * 1999-04-28 2000-11-02 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
WO2002090961A2 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US20060194267A1 (en) * 2005-02-25 2006-08-31 Aristo Vojdani Methods and kit for diagnosing tick borne illnesses
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6015002357; Ｉｎｔｅｒｎａｔｉｏｎａｌ　Ｊｏｕｒｎａｌ　ｏｆ　Ｍｅｄｉｃａｌ　Ｍｉｃｒｏｂｉｏｌｏｇｙ Ｖｏｌ．２９９, 2009, ｐ．４３９-４４６ *

Also Published As

Publication number Publication date
CN102791727A (zh) 2012-11-21
WO2011063003A2 (en) 2011-05-26
KR20120096932A (ko) 2012-08-31
CA2781110C (en) 2018-07-31
WO2011063003A3 (en) 2011-09-01
EP2501719B1 (en) 2015-11-04
AU2010322085A1 (en) 2012-07-05
EP2501719A2 (en) 2012-09-26
AU2010322085B2 (en) 2016-09-15
CA2781110A1 (en) 2011-05-26
US8568989B2 (en) 2013-10-29
EP2501719A4 (en) 2013-07-31
US20110136155A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
US11573227B2 (en) Peptides and methods for the detection of Lyme disease antibodies
US8568989B2 (en) Peptides and methods for the detection of Lyme disease antibodies
US10948487B2 (en) Peptides, devices, and methods for the detection of Ehrlichia antibodies
JP6161291B2 (ja) エールリッヒア抗体の検出のためのペプチド、装置、および方法
KR20160108521A (ko) 아나플라즈마 항체의 검출을 위한 펩티드, 장치 및 방법
HK40102336A (en) Peptides and methods for the detection of lyme disease antibodies
HK40010384B (en) Peptides and methods for the detection of lyme disease antibodies
HK40010384A (en) Peptides and methods for the detection of lyme disease antibodies

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150417

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150519

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150907